MAPK14 and neoplasm: Since cancer stem cells (CSCs) and quiescent tumor cells share signaling pathways, as in the case of mitogen-activated protein kinase P38 (P38 MAPK), the development of therapeutic approaches targeting p38 may increase tumor sensitivity to chemotherapy and prevent progression and metastasis.